Moore, M. C., Smith, M. S., Sinha, V. P., Beals, J. M., Michael, M. D., Jacober, S. J., & Cherrington, A. D. (2014). Novel PEGylated Basal Insulin LY2605541 Has a Preferential Hepatic Effect on Glucose Metabolism. Diabetes.
Citação norma ChicagoMoore, Mary Courtney, Marta S. Smith, Vikram P. Sinha, John M. Beals, M. Dodson Michael, Scott J. Jacober, and Alan D. Cherrington. "Novel PEGylated Basal Insulin LY2605541 Has a Preferential Hepatic Effect On Glucose Metabolism." Diabetes 2014.
Deismireacht MLAMoore, Mary Courtney, et al. "Novel PEGylated Basal Insulin LY2605541 Has a Preferential Hepatic Effect On Glucose Metabolism." Diabetes 2014.
Rabhadh: D'fhéadfadh nach mbeadh na deismireachtaí seo 100% cruinn i gcónaí.